Along with the correlations between MTF1 expression and immune-associated molecules, including immune stimulators, immune inhibitors, chemokines, and MHCs, we suggested that MTF1 may be predictive of the tumor immune microenvironment and immunotherapy efficacy in a variety of cancers. The gene discussed is MTF1; the disease is cancer.